IRIS
PETRIOLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.835
EU - Europa 3.219
AS - Asia 1.780
SA - Sud America 263
AF - Africa 92
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.198
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.757
RU - Federazione Russa 769
IT - Italia 615
SG - Singapore 557
GB - Regno Unito 537
CN - Cina 531
IE - Irlanda 403
VN - Vietnam 266
BR - Brasile 206
SE - Svezia 183
DE - Germania 153
UA - Ucraina 148
FR - Francia 145
HK - Hong Kong 133
FI - Finlandia 81
IN - India 61
KR - Corea 56
CA - Canada 53
ZA - Sudafrica 49
BD - Bangladesh 36
ES - Italia 36
NL - Olanda 24
PL - Polonia 24
AR - Argentina 21
BE - Belgio 21
LU - Lussemburgo 18
TR - Turchia 18
JP - Giappone 15
MX - Messico 15
IQ - Iraq 13
PK - Pakistan 13
CL - Cile 12
CI - Costa d'Avorio 11
AT - Austria 9
IR - Iran 9
NG - Nigeria 9
LT - Lituania 8
RO - Romania 8
VE - Venezuela 8
ID - Indonesia 7
JO - Giordania 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
MA - Marocco 6
AU - Australia 5
EC - Ecuador 5
MY - Malesia 5
PH - Filippine 5
TH - Thailandia 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CH - Svizzera 4
CO - Colombia 4
KZ - Kazakistan 4
TN - Tunisia 4
UZ - Uzbekistan 4
CR - Costa Rica 3
DK - Danimarca 3
KE - Kenya 3
NO - Norvegia 3
TW - Taiwan 3
AL - Albania 2
CD - Congo 2
EE - Estonia 2
ET - Etiopia 2
GT - Guatemala 2
HU - Ungheria 2
JM - Giamaica 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
MM - Myanmar 2
MW - Malawi 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
PY - Paraguay 2
SV - El Salvador 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
DZ - Algeria 1
EG - Egitto 1
EU - Europa 1
FJ - Figi 1
GE - Georgia 1
GR - Grecia 1
IL - Israele 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
NI - Nicaragua 1
NP - Nepal 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
Totale 9.195
Salva come PNG Salva come JPEG
Città #
Dallas 513
Southend 455
Dublin 399
Fairfield 380
Singapore 325
Ashburn 324
Moscow 231
San Jose 209
Santa Clara 175
Woodbridge 166
Chandler 158
Cambridge 138
Milan 138
Wilmington 138
Beijing 137
Seattle 133
Ann Arbor 127
Jacksonville 126
Hong Kong 123
Houston 112
Siena 88
New York 81
Ho Chi Minh City 78
Los Angeles 75
Hefei 68
Princeton 68
Hanoi 64
Council Bluffs 55
Munich 53
Seoul 53
Johannesburg 49
Rome 47
Lauterbourg 46
Shanghai 42
Helsinki 38
Nanjing 35
Florence 33
The Dalles 32
Dong Ket 29
San Mateo 28
Málaga 24
São Paulo 23
San Diego 22
Buffalo 21
Brussels 20
Boardman 19
Montreal 19
Orem 19
Columbus 18
London 17
San Francisco 17
Turku 17
Warsaw 17
Shenyang 16
Denver 14
Roodt-sur-Syre 14
Chennai 13
Da Nang 13
Tokyo 13
Chicago 12
Frankfurt am Main 12
Redondo Beach 12
Abidjan 11
Haiphong 11
Nuremberg 11
Brooklyn 10
Figino 10
Guangzhou 10
Kunming 10
Phoenix 10
Atlanta 9
Baghdad 9
Jiaxing 9
Manchester 9
Pisa 9
Santiago 9
Abuja 8
Arezzo 8
Tianjin 8
Toronto 8
Düsseldorf 7
Mexico City 7
Nanchang 7
Poplar 7
Portsmouth 7
Amsterdam 6
Bengaluru 6
Dearborn 6
Fremont 6
Hebei 6
Mumbai 6
North Bergen 6
Redwood City 6
Venezia 6
Washington 6
Zanjan 6
Zhengzhou 6
Amman 5
Aosta 5
Changsha 5
Totale 6.232
Salva come PNG Salva come JPEG
Nome #
Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ≥ 75 Years With Metastatic Colorectal Cancer (mCRC) After Failure of 2 Lines of Chemotherapy 323
28. Role of neoadjuvant chemotherapy with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for treatment of primary ovarian cancer with peritoneal carcinomatosis 318
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer 316
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer 308
Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer 294
A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer 280
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives 279
Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer 265
Signet ring cell percentage in poorly cohesive gastric cancer patients: a potential novel predictor of survival 265
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer 264
Two-point-NGS analysis of cancer genes in cell-free DNA of metastatic cancer patients 264
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study 263
Efficacy of Adjuvant Fluorouracil and Folinic Acid in B2 Colon Cancer 262
Analysis of biochemical bone markers as prognostic factors for survival in patients with hormone-resistant prostate cancer and bone metastases 258
CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab 255
The percentage of signet ring cells is inversely related to aggressive behavior and poor prognosis in mixed-type gastric cancer 250
A case of eribulin-induced regression of liposarcoma of the left funiculus in a heavily pretreated patient 219
GEMCITABINE (dFdC), 5-FLUROURACIL (5FU), AND FOLINIC ACID (FA) IN THE TREATMENT OF PATIENTS WITH GASTRO-ENTERIC CARCINOMAS: A CLINICAL AND PHARMACOLOGICAL STUDY. 215
Gastric cancer: Current status of lymph node dissection 213
The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study: TILs for ADJ-untreated stage II colon cancer 209
Short-term and long-term risk factors in gastric cancer 203
Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal Cancer 198
Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: A meta-analysis of four randomized trials 195
Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials 187
Posterior and Para-Aortic (D2plus) Lymphadenectomy after Neoadjuvant/Conversion Therapy for Locally Advanced/Oligometastatic Gastric Cancer 182
Hyperprogressive disease in advanced cancer patients treated with nivolumab: a case series study 172
An exceptional overall survival using bevacizumab beyond progression in a patient with Non-small cell lung cancer 170
Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer 169
Cytoreduction surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as treatment choice of metastatic Urachal carcinoma 156
Association of Concomitant Bone Resorption Inhibitors with Overall Survival among Patients with Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate with Prednisone as First-Line Therapy 155
Preoperative or perioperative docetaxel, oxaliplatin, and capecitabine (GASTRODOC regimen) in patients with locally-advanced resectable gastric cancer: a randomized phase-II trial 154
Neuroendocrine tumors' patients treated with somatostatin analogue could complicate with emergency cholecystectomy 151
Impact of HER2 and microsatellite instability status on response to neoadjuvant/conversion therapy and survival in patients with gastric cancer 149
Structured and shared CT radiological report of gastric cancer: a consensus proposal by the Italian Research Group for Gastric Cancer (GIRCG) and the Italian Society of Medical and Interventional Radiology (SIRM) 142
Low-Dose Estramustine Phosphate and Concomitant Low-Dose Acetylsalicylic Acid in Heavily Pretreated Patients With Advanced Castration-Resistant Prostate Cancer. 142
Squamous cell carcinoma of the maxillary sinus: A retrospective analysis of 36 cases 127
Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate 126
Specific clonal expansion at disease progression (PD) in solid cancers pinpointed by cell free DNA analysis 123
Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience. 121
Thymostimulin in Association with Chemotherapy in Breast Cancer Patients with Bone Metastases 121
Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence 118
A husband and a wife with simultaneous presentation of glioblastoma multiforme: a case report 101
null 98
null 96
Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Malignancies with Palliative and Bidirectional Intent 94
null 89
null 88
null 87
Rare variants modulating phenotype in NF1 carriers 85
null 39
Totale 9.358
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.702
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022564 45 60 37 33 22 29 24 31 23 50 84 126
2022/2023683 39 53 98 66 62 149 23 58 65 32 21 17
2023/2024701 27 15 70 38 26 173 220 9 0 32 45 46
2024/20251.263 58 67 123 87 163 90 29 77 135 44 144 246
2025/20263.714 254 429 425 444 745 151 449 95 121 205 135 261
2026/202756 56 0 0 0 0 0 0 0 0 0 0 0
Totale 9.358